96 related articles for article (PubMed ID: 21800013)
1. Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase.
Rukoyatkina N; Walter U; Friebe A; Gambaryan S
Thromb Haemost; 2011 Nov; 106(5):922-33. PubMed ID: 21800013
[TBL] [Abstract][Full Text] [Related]
2. Abacavir increases platelet reactivity via competitive inhibition of soluble guanylyl cyclase.
Baum PD; Sullam PM; Stoddart CA; McCune JM
AIDS; 2011 Nov; 25(18):2243-8. PubMed ID: 21941165
[TBL] [Abstract][Full Text] [Related]
3. Antiplatelet Effects of Flavonoid Aglycones Are Mediated by Activation of Cyclic Nucleotide-Dependent Protein Kinases.
Balykina A; Naida L; Kirkgöz K; Nikolaev VO; Fock E; Belyakov M; Whaley A; Whaley A; Shpakova V; Rukoyatkina N; Gambaryan S
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732081
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways.
Ridnour LA; Windhausen AN; Isenberg JS; Yeung N; Thomas DD; Vitek MP; Roberts DD; Wink DA
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):16898-903. PubMed ID: 17942699
[TBL] [Abstract][Full Text] [Related]
5. Cyclic Guanosine Monophosphate Modulates Locomotor Acceleration Induced by Nitric Oxide but not Serotonin in
Pirtle TJ; Satterlie RA
Integr Org Biol; 2021; 3(1):obaa045. PubMed ID: 33791588
[TBL] [Abstract][Full Text] [Related]
6. Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.
Zhang G; Xiang B; Dong A; Skoda RC; Daugherty A; Smyth SS; Du X; Li Z
Blood; 2011 Sep; 118(13):3670-9. PubMed ID: 21803853
[TBL] [Abstract][Full Text] [Related]
7. Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation.
Mauersberger C; Sager HB; Wobst J; Dang TA; Lambrecht L; Koplev S; Stroth M; Bettaga N; Schlossmann J; Wunder F; Friebe A; Björkegren JLM; Dietz L; Maas SL; van der Vorst EPC; Sandner P; Soehnlein O; Schunkert H; Kessler T
Nat Cardiovasc Res; 2022 Dec; 1(12):1174-1186. PubMed ID: 37484062
[TBL] [Abstract][Full Text] [Related]
8. The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function.
Gambaryan S
Cells; 2022 Nov; 11(22):. PubMed ID: 36429131
[TBL] [Abstract][Full Text] [Related]
9. Platelet Redox Imbalance in Hypercholesterolemia: A Big Problem for a Small Cell.
Morotti A; Barale C; Melchionda E; Russo I
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232746
[TBL] [Abstract][Full Text] [Related]
10. The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders.
Degjoni A; Campolo F; Stefanini L; Venneri MA
J Thromb Haemost; 2022 Nov; 20(11):2465-2474. PubMed ID: 35950928
[TBL] [Abstract][Full Text] [Related]
11. The Antiplatelet Action of S-Nitroso Human Serum Albumin in Whole Blood.
Tsiountsioura M; Cvirn G; Schlagenhauf A; Haidl H; Zischmeier K; Janschitz N; Koestenberger M; Wonisch W; Paar M; Wagner T; Weiss EC; Hallström S
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327451
[TBL] [Abstract][Full Text] [Related]
12. Molecular Proteomics and Signalling of Human Platelets in Health and Disease.
Huang J; Zhang P; Solari FA; Sickmann A; Garcia A; Jurk K; Heemskerk JWM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576024
[TBL] [Abstract][Full Text] [Related]
13. Mitoquinone (MitoQ) Inhibits Platelet Activation Steps by Reducing ROS Levels.
Méndez D; Arauna D; Fuentes F; Araya-Maturana R; Palomo I; Alarcón M; Sebastián D; Zorzano A; Fuentes E
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867213
[TBL] [Abstract][Full Text] [Related]
14. Anti-platelet drugs and their necessary interaction with endothelial mediators and platelet cyclic nucleotides for therapeutic efficacy.
Knowles RB; Warner TD
Pharmacol Ther; 2019 Jan; 193():83-90. PubMed ID: 30081048
[TBL] [Abstract][Full Text] [Related]
15. Cyclic nucleotide-dependent inhibitory signaling interweaves with activating pathways to determine platelet responses.
Nagy Z; Smolenski A
Res Pract Thromb Haemost; 2018 Jul; 2(3):558-571. PubMed ID: 30046761
[TBL] [Abstract][Full Text] [Related]
16. Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy.
Jayakumar T; Hsu CY; Khamrang T; Hsia CH; Hsia CW; Manubolu M; Sheu JR
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925802
[TBL] [Abstract][Full Text] [Related]
17. cGMP Signaling and Vascular Smooth Muscle Cell Plasticity.
Lehners M; Dobrowinski H; Feil S; Feil R
J Cardiovasc Dev Dis; 2018 Apr; 5(2):. PubMed ID: 29671769
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase A activation by the anti-cancer drugs ABT-737 and thymoquinone is caspase-3-dependent and correlates with platelet inhibition and apoptosis.
Rukoyatkina N; Butt E; Subramanian H; Nikolaev VO; Mindukshev I; Walter U; Gambaryan S; Benz PM
Cell Death Dis; 2017 Jun; 8(6):e2898. PubMed ID: 28661475
[TBL] [Abstract][Full Text] [Related]
19. Modulation of Local and Systemic Heterocellular Communication by Mechanical Forces: A Role of Endothelial Nitric Oxide Synthase.
Erkens R; Suvorava T; Kramer CM; Diederich LD; Kelm M; Cortese-Krott MM
Antioxid Redox Signal; 2017 Jun; 26(16):917-935. PubMed ID: 27927026
[TBL] [Abstract][Full Text] [Related]
20. Erythrocytes do not activate purified and platelet soluble guanylate cyclases even in conditions favourable for NO synthesis.
Gambaryan S; Subramanian H; Kehrer L; Mindukshev I; Sudnitsyna J; Reiss C; Rukoyatkina N; Friebe A; Sharina I; Martin E; Walter U
Cell Commun Signal; 2016 Aug; 14(1):16. PubMed ID: 27515066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
